Clincosm LogoSign in Get a demo

Castrate Resistant Prostate Cancer

Showing 1 - 22 of 22
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Castrate Resistant Prostate Cancer, Metastatic Castration-resistant Prostate Cancer, Prostate Cancer Trial in San Francisco

Not yet recruiting
  • Castrate Resistant Prostate Cancer
  • +3 more
  • San Francisco, California
    University of California, San Francisco
Mar 1, 2023

Prostate Cancer, Castrate Resistant Prostate Cancer Trial (Enzalutamide 40 MG, Docetaxel injection)

Not yet recruiting
  • Prostate Cancer
  • Castrate Resistant Prostate Cancer
  • Enzalutamide 40 MG
  • Docetaxel injection
  • (no location specified)
Jan 27, 2023

Prostate Cancer Metastatic, Castrate Resistant Prostate Cancer, Metastatic Castration-resistant Prostate Cancer Trial in Herlev

Recruiting
  • Prostate Cancer Metastatic
  • +3 more
  • Stereotactic body radiotherapy
  • +3 more
  • Herlev, Capital Region, Denmark
    Department of Oncology, Copenhagen University Hospital Herlev an
Dec 16, 2022

Metastatic Castration-resistant Prostate Cancer, Prostate Cancer Metastatic, Castrate Resistant Prostate Cancer Trial in

Not yet recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • +2 more
  • Vancouver, British Columbia, Canada
    BC Cancer
Nov 28, 2022

Metastatic Prostate Cancer, Prostate Cancer Metastatic, Prostate Cancer Trial in United States (Darolutamide, Enzalutamide)

Recruiting
  • Metastatic Prostate Cancer
  • +3 more
  • San Diego, California
  • +11 more
Nov 28, 2022

Nasopharyngeal Carcinoma, Castrate Resistant Prostate Cancer, Gastric Cancer Trial in New Haven (APG-5918)

Recruiting
  • Nasopharyngeal Carcinoma
  • +8 more
  • Springdale, Arkansas
    Highlands Oncology
Nov 11, 2022

Anal Squamous Cell Carcinoma, Colorectal Tumors, Soft Tissue Sarcoma Trial (Regorafenib in combination with Tislelizumab)

Not yet recruiting
  • Anal Squamous Cell Carcinoma
  • +7 more
  • Regorafenib in combination with Tislelizumab
  • (no location specified)
Oct 12, 2022

Glioma, Glioma, Malignant, Glioma, Mixed Trial in United States (NUV-422)

Terminated
  • Glioma
  • +23 more
  • Tucson, Arizona
  • +11 more
Sep 30, 2022

Castrate Resistant Prostate Cancer, NUT Carcinoma Trial (EP31670)

Not yet recruiting
  • Castrate Resistant Prostate Cancer
  • NUT Carcinoma
  • (no location specified)
Aug 3, 2022

Advanced Solid Tumor, Ovarian Cancer, Ovary Cancer Trial in United States (NUV-868, Olaparib, Enzalutamide)

Recruiting
  • Advanced Solid Tumor
  • +26 more
  • Baltimore, Maryland
  • +3 more
Aug 1, 2022

Castrate Resistant Prostate Cancer Trial in Chicago, Indianapolis, Hershey (Ipatasertib, Darolutamide, Androgen Deprivation

Recruiting
  • Castrate Resistant Prostate Cancer
  • Chicago, Illinois
  • +2 more
Jul 19, 2022

Ewing Sarcoma, Myxoid/Round Cell Liposarcoma, Synovial Sarcoma Trial in United States (PRT2527)

Recruiting
  • Ewing Sarcoma
  • +7 more
  • Denver, Colorado
  • +5 more
Jun 9, 2022

Prostate Cancer Metastatic, Castrate Resistant Prostate Cancer, Metastatic Prostate Cancer Trial in San Antonio (High Intensity

Recruiting
  • Prostate Cancer Metastatic
  • +3 more
  • High Intensity Interval Training
  • San Antonio, Texas
    UT Health San Antonio
Feb 17, 2022

Prostate Cancer, Prostatic Cancer, Cancer of Prostate Trial (NUV-422, Enzalutamide)

Not yet recruiting
  • Prostate Cancer
  • +7 more
  • (no location specified)
Jan 12, 2022

Advanced Prostate Carcinoma, Cancer of Prostate, PSA Trial in Melbourne (Darolutamide, Radiotherapy)

Recruiting
  • Advanced Prostate Carcinoma
  • +3 more
  • Melbourne, Victoria, Australia
    Peter MacCallum Cancer Center
Aug 26, 2021

Prostate Cancer, Castrate Resistant Prostate Cancer Trial (Abiraterone Acetate, Sodium Selenite, Prednisone)

Withdrawn
  • Prostate Cancer
  • Castrate Resistant Prostate Cancer
  • Abiraterone Acetate
  • +2 more
  • (no location specified)
Aug 5, 2021

Health-related Quality of Life, Psychological Distress and

Completed
  • Castrate Resistant Prostate Cancer
  • Bone Metastases
  • 's-Hertogenbosch, Netherlands
  • +10 more
Jul 29, 2021

Castrate Resistant Prostate Cancer, Prostate Cancer Trial in Iowa City (PET Acetate scan, Carbon-11 labeled Acetate)

Completed
  • Castrate Resistant Prostate Cancer
  • Prostate Cancer
  • PET Acetate scan
  • Carbon-11 labeled Acetate
  • Iowa City, Iowa
    University of Iowa Hospitals and Clinics
Sep 30, 2018

Castrate Resistant Prostate Cancer, Chemo Naive Prostate Cancer, Prostate Cancer Trial in New Haven, Philadelphia (Pasireotide,

Terminated
Has Results
  • Castrate Resistant Prostate Cancer
  • +2 more
  • New Haven, Connecticut
  • +1 more
Apr 23, 2018

Prostate Cancer, Castrate Resistant Prostate Cancer Trial in Marina del Rey (sipuleucel-T, ipilimumab)

Completed
  • Prostate Cancer
  • Castrate Resistant Prostate Cancer
  • Marina del Rey, California
    Prostate Oncology Specialists, Inc.
Aug 23, 2017

Castrate Resistant Prostate Cancer Trial in London (Melphalan, Lenograstim)

Unknown status
  • Castrate Resistant Prostate Cancer
  • London, United Kingdom
    St Batholowmew's Hospital NHS
Sep 7, 2015

Castrate Resistant Prostate Cancer Trial in Belgium, France, United Kingdom (ASP9521)

Terminated
  • Castrate Resistant Prostate Cancer
  • Antwerp, Belgium
  • +3 more
Mar 21, 2014